DrugCards
Ukrainian health-tech / pharma-tech startup that reduces costs for drug safety activities by 30 percent for pharma companies and CROs.
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 125 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
DrugCard.io is a pioneering startup that specializes in automating the local literature screening process for drug safety teams. Operating in the pharmaceutical and healthcare sectors, DrugCard.io serves clients such as pharmaceutical companies, regulatory bodies, and research institutions. The company leverages advanced AI technology to streamline the traditionally time-consuming task of literature monitoring, making it significantly faster and more efficient.
The core service provided by DrugCard.io is a Software as a Service (SaaS) platform that offers continuous, regular, and transparent literature screening in multiple languages. This platform is accessible 24/7 from any device, ensuring that users can perform their tasks at any time. The service covers over 50 countries and includes results from indexed journals in PubMed as well as local literature. This broad coverage is crucial for maintaining compliance with regulatory standards in various markets, including the EU, US, and CIS regions.
DrugCard.io's business model is subscription-based, where clients pay a recurring fee to access the platform. This model ensures a steady revenue stream while providing clients with ongoing value. The platform's ability to save 50-70% of the time typically spent on literature screening translates into significant cost savings for its users. For example, a task that would normally take 35 minutes can be completed in just 3 minutes using DrugCard.io, freeing up valuable time for other critical activities.
The company also emphasizes data integrity and compliance, adhering to FDA CFR 21 Part 11 regulations for electronic records and signatures. This compliance is essential for clients who need to meet stringent regulatory requirements.
In summary, DrugCard.io offers a unique, AI-driven solution that automates local literature screening, providing substantial time and cost savings while ensuring regulatory compliance. This makes it an invaluable tool for drug safety teams aiming to maximize their efficiency and effectiveness.
Keywords: AI-driven, literature screening, pharmaceutical, healthcare, SaaS, compliance, regulatory, cost-effective, multi-language, PubMed.